“Red wine may be much more potent than was thought in extending human lifespan, researchers say in a new report that is likely to give impetus to the rapidly growing search for longevity drugs.”
So says an interesting article in today’s International Herald Tribune on the anti-aging effects of red wine.
Pharma giant GlaxoSmithKline has just bought, for $720 million, a startup called Sirtris whicxh was founded in 2004 to cary out research into anti-aging. It is said that the research is based on an ancient biological survival mechanism, called resveratrol, present in red wine. This switches the body’s resources from fertility to tissue maintenance. The improved tissue maintenance seems to extend life by cutting down on the degenerative diseases of aging.
Apparently mice in tests would have had to take the equivalent of 100 bottles of red wine each per day (!) to see results in initial tests… but finally scientists have caught on to the fact that red wine contains many other resveratrol-like compounds that may also be beneficial.
Maybe the conclusion of all this, and what GlaxoSmithKline will learn for their $720 million, is that we can better just drink a glass or two of red wine a day and forget about trying to put wine in capsule form?